Old Web
English
Sign In
Acemap
>
Paper
>
51PActive immunotherapy with a VEGF targeted vaccine HeberSaVax: The road so far and the future ahead
51PActive immunotherapy with a VEGF targeted vaccine HeberSaVax: The road so far and the future ahead
2018
Mónica Bequet-Romero
Yanelys Morera Díaz
Javier Sánchez Ramírez
K-H Selman-Housein
Francisco Hernández-Bernal
A de la Torre Santos
J. Piñero
C Bermúdez
J V Gavilondo Cowley
M. Ayala Ávila
Keywords:
Pathology
Cancer research
Medicine
Vascular endothelial growth factor A
VEGF receptors
Immunotherapy
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]